Evidence map›Paper›PMID 41420714›Full record

ArticleCellular and molecular life sciences : CMLS2025

ZAR1 pathogenic variants disrupt maternal mRNA storage and cause oocyte maturation defects in humans.

Xiu-Quan Liao, Shuai Zhao, Chang-Long Zhang, Yan Zhu, Jun Wen, Yang Wang, Shao-Yuan Liu, Wei Su, Jiang-Tao Zhang, Qiong-Wen Lu and 6 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xiu-Quan Liao *GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.
Shuai Zhao *State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine,Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Chang-Long Zhang *State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine,Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Yan Zhu *Medical Experimental Center, Guangdong Second Provincial General Hospital, Guangzhou, China.
Jun WenGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.
Yang WangMOE Key Laboratory for Biosystems Homeostasis and Protection and Innovation Center for Cell Signaling Network Life Sciences Institute Zhejiang University, Hangzhou, China.
Shao-Yuan LiuGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.
Wei SuState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine,Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Jiang-Tao ZhangState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine,Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Qiong-Wen LuSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China.
Fei GongClinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-XIANGYA, Changsha, China.
Ge LinClinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-XIANGYA, Changsha, China.
Heng-Yu FanMOE Key Laboratory for Biosystems Homeostasis and Protection and Innovation Center for Cell Signaling Network Life Sciences Institute Zhejiang University, Hangzhou, China. hyfan@zju.edu.cn.
Wei ZhengCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China. ustczw@163.com.
Han ZhaoState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine,Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China. hanzh80@sdu.edu.cn.
Qian-Qian ShaGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China. shaqianqian@zju.edu.cn.ORCID http://orcid.org/0000-0001-9622-5201

Funding

2021YFA1100300 2021YFA1100300202201011005 2022010110052022B1515020038 2022B15150200382023RC3233 2023RC32332023YFC2705504 2023YFC270550432270894 3227089482192874 82192874
6 · The paper itself

Abstract

Zygote arrest 1 (Zar1) was one of the earliest identified maternal-effect genes that function during the maternal-to-zygotic transition (MZT) in mice. However, the role of human ZAR1 remains unclear. In this study, we investigated the association of ZAR1 gene variants with infertility in women, focusing on their impact on oocyte maturation and early embryonic development. Using whole-exome sequencing, we identified homozygous and compound heterozygous ZAR1 variants in two independent families with female patients diagnosed with primary infertility owing to oocyte maturation and early embryonic arrest. Functional analysis revealed that the V118A variant disrupted the localization of ZAR1 to the mitochondria-associated ribonucleoprotein domain (MARDO) structure, which is a key mRNA storage site in oocytes. The R397Q and S121* mutations impaired ZAR1’s RNA-binding capability, indirectly affecting its subcellular localization and the integrity of MARDO. These variants disrupted MARDO formation and function, leading to defective oocyte maturation and early embryonic development. This study highlights the critical roles of ZAR1 and MARDO in human reproduction and provides insights into the molecular mechanisms underlying some forms of female infertility.

Indexed as

Egg ProteinsInfertility, FemaleOocytesRNA, Messenger, StoredAnimalsEmbryonic DevelopmentFemaleHumansMutationOogenesisPedigreeRNA-Binding ProteinsRNA, MessengerEgg ProteinsRNA-Binding ProteinsRNA, MessengerRNA, Messenger, StoredFemale infertilityMARDOOocytePost transcriptional regulationRNA binding protein

Identifiers

PMID41420714
PMCPMC12799850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.